Abstract:Abstract Background Cystic Fibrosis is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, which encodes for a chloride/bicarbonate anion channel expressed on the apical membrane of most epithelial tissues, such as the lungs, liver, pancreas, small and large intestines, and reproductive tissues. CFTR is responsible for the transport of chloride and bicarbonate ions to maintain tissue surface hydration and pH balance of epithelial tissues. Historically, recurrent lung infections have been the most common cause of mortality in CF patients. With advances in clinical care and therapeutics, the current mean survival age of Canadian patients has increased to 52.3 years. However, this increase in survival has also been associated with an elevated risk of developing gastrointestinal cancers in CF adults. Compared to the general public, CF patients are 10 times more likely to develop cancer. This risk is increased to 25-20 times in patients that have undergone organ transplantations. Although the exact molecular mechanism regarding increased cancer risk in CF remains unclear, chronic intestinal inflammation has been known to contribute to elevated cancer development. Aims CF patients display an increased baseline inflammatory status that is exacerbated with microbiome exposure leading to possible increased risk for inflammation-mediated cancer development. Methods To reduce inter-patient heterogeneity, we have differentiated human intestinal organoids using induced pluripotent stem cells from homozygous F508del CF patients and gene edited isogenic non-CF (Wt-CFTR) controls. We conducted gene expression studies using RT-qPCR to determine baseline differences in gene expression prior to environmental exposures and following exposure to LPS and flagellin. Results We determined the expression levels of stem cell, intestinal epithelial cell, innate immunity genes and differentiation markers and found expression of such genes were not significantly different between 3D CF and gene-edited non-CF organoids. We are currently conducting RNA sequencing to survey expression pattern of all genes to definitively determine possible fundamental changes in the CF intestinal epithelium and determining the effect of LPS and flagellin treatment to determine if there is an altered response to inflammatory stimuli. Conclusions iPSC derived HIOs is a novel, patient based, and renewable model that can be used to dissect the primary intestinal pathologies in CF. Transcriptomic data of CF HIOs at steady state will provide insights to possible developmental defects. Complex interactions between the host intestinal epithelia and the commensal microbiome can also be investigated using this model. Funding Agencies CAG

S2948 Distal Intestinal Obstruction Syndrome From Cystic Fibrosis

International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome

Constipation and DIOS: Diagnosis, differential diagnosis, and management

Effectiveness of an Oral Gastrografin Regimen for Complete Distal Intestinal Obstruction Syndrome

Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth.

Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction

Synchronous volvulus of the sigmoid and transverse colon in a 26-year-old male

S4810 Obstructive Conundrum: Desmoid Fibromatosis as a Rare Cause of Small Bowel Obstruction

S4827 Severe Scleroderma Presenting With High Grade Distal Small Bowel Obstruction

Ostomy in continuity: A novel approach for the management of children with complex short bowel syndrome

Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon): a report of 5 cases.

Upper Gastrointestinal Tract Obstruction Due to Congenital Duodenal Diaphragm.

Abdominal Cocoon Presenting As Subacute Intestinal Obstruction

Abdominal Cocoon Syndrome: An Extremely Rare Cause of Small Bowel Obstruction

Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota?

Chronic intestinal pseudo-obstruction due to adult-onset acquired isolated hypoganglionosis with muscular atrophy in the small intestine: a case report and review of literature

Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients

A115 MODELING CYSTIC FIBROSIS (CF) INTESTINAL DISEASE USING PATIENT DERIVED TISSUES

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis

S4951 A Rare Manifestation of Celiac Disease: Recurrent Small Bowel Jejunojejunal Intussusception

Pediatric Intestinal Pseudo-obstruction in the Era of Genetic Sequencing